According to a recent LinkedIn post from Cleerly, the company is promoting a Heart Month webinar focused on women’s heart health, led by preventive cardiologist Dr. Suzanne Steinbaum. The event will address sex-specific cardiovascular risk, the role of plaque, diagnostic limitations, and the use of data to support greater equity in care.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that Cleerly is positioning its AI-enabled coronary CT (AIQCT) and digital health capabilities within evidence-based, clinically relevant workflows for diagnosing and managing coronary artery disease. For investors, this emphasis on education and thought leadership in women’s heart health could help deepen clinician engagement, strengthen brand credibility in cardiology, and support longer-term adoption of its imaging and analytics platform.